Now showing items 1-10 of 10

    • Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals 

      Schifano, Fabrizio; Catalani, Valeria; Sharif, Safia (Sophia); Napoletano, Flavia; Corkery, John; Arillotta, Davide; Fergus, Suzanne; Vento, Alessandro; Guirguis, Amira (2022-04-02)
      ‘Smart drugs’ (also known as ‘nootropics’ and ‘cognitive enhancers’ [CEs]) are being used by healthy subjects (i.e. students and workers) typically to improve memory, attention, learning, executive functions and vigilance, ...
    • The clinical challenges of synthetic cathinones 

      Schifano, Fabrizio; Napoletano, Flavia; Arillotta, Davide; Zangani, Caroline; Gilgar, Liam; Guirguis, Amira; Corkery, John; Vento, Alessandro (2019-11-01)
      Within the new psychoactive substances (NPS) scenario, several hundreds of different molecules, mostly including synthetic cannabinoids and cathinones, have so far been identified. The aims of the paper were to: (a) identify ...
    • The e-psychonauts’ ‘Spiced’ World; assessment of the synthetic cannabinoids’ information available online 

      Zangani, Caroline; Schifano, Fabrizio; Napoletano, Flavia; Arillotta, Davide; Gilgar, Liam; Guirguis, Amira; Corkery, John Martin; Gambini, Orsola; Vento, Alessandro (2020-03-02)
      Background: A wide range of novel psychoactive substances (NPS) is regularly searched and discussed online by web-based drug enthusiasts (i.e. the e-psychonauts). Among NPS, the range of synthetic cannabinoids (SC; ‘Spice’) ...
    • New Psychoactive Substances (NPS) and Serotonin Syndrome onset: a Systematic Review 

      Schifano, Fabrizio; Chiappini, Stephania; Corkery, John; Scherbaum, Norbert; Napoletano, Flavia; Arillotta, Davide; Catalani, Valeria; Vento, Alessandro; Pettorruso, Mauro; Martinotti, Giovanni; di Giannantonio, Massimo; Guirguis, Amira (2021-05-01)
      The use of several new psychoactive substances (NPS) has become very popular and is posing global health risks. Chemically and pharmacologically diverse molecules are constantly emerging and are presenting with a wide range ...
    • New psychoactive substances (NPS), psychedelic experiences, and dissociation: clinical and clinical pharmacological issues 

      Schifano, Fabrizio; Napoletano, Flavia; Chiappini, Stephania; Orsolini, Laura; Guirguis, Amira; Corkery, John Martin; Bonaccorso, Stefania; Ricciardi, Angelo; Scherbaum, Norbert; vento, alessandro (2019-04-23)
      Purpose of the review: A significant increase in the number, type, and availability of new psychoactive substances (NPS) with dissociative and psychedelic potential has occurred worldwide over the last few decades. Psychedelic ...
    • New/emerging psychoactive substances and associated psychopathological consequences 

      Schifano, Fabrizio; Napoletano, Flavia; Chiappini, Stephania; Guirguis, Amira; Corkery, John; Bonaccorso, Stefania; Ricciardi, Angelo; Scherbaum, Norbert; vento, alessandro (2019-07-22)
      BackgroundThe present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification ...
    • Novel opioids: systematic web crawling within the e-psychonauts’ scenario 

      Arillotta, Davide; Schifano, Fabrizio; Napoletano, Flavia; Zangani, Caroline; Gilgar, Liam; Guirguis, Amira; Corkery, John Martin; Aguglia, E; vento, alessandro (2020-03-18)
      Background: A wide range of novel psychoactive substances (NPSs) are regularly searched and discussed online by e-psychonauts. Among NPSs, the range of prescription/non-prescription opioids (fentanyl and non-fentanyl ...
    • The psychonauts' world of cognitive enhancers 

      Napoletano, Flavia; Schifano, Fabrizio; Corkery, John Martin; Guirguis, Amira; Arillotta, Davide; Zangani, Caroline; Vento, Alessandro (2020-09-11)
      Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. Whilst treating cognitive deficit ...
    • Psychonauts’ psychedelics: a systematic, multilingual, web-crawling exercise 

      Catalani, Valeria; Corkery, John Martin; Guirguis, Amira; Napoletano, Flavia; Arillotta, Davide; Zangani, Caroline; Vento, Alessandro; Schifano, Fabrizio (2021-08-01)
      Psychedelics alter the perception of reality through agonist or partial agonist interaction with the 2A serotoninergic receptor. They are classified as phenethylamines, tryptamines and lysergamides. These classes, according ...
    • Treatment of kratom use disorder with a classical tricyclic antidepressant: A case report and review 

      Vento, Alessandro; de Persis, Simone; De Filippis, Sergio; Schifano, Fabrizio; Napoletano, Flavia; Corkery, John Martin; Kotzalidis, Georgios D. (2021-03-31)
      Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe ...